{"brief_title": "Trial of Buprenorphine/Naloxone for Opiate Dependence - 2", "brief_summary": "The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.", "condition": ["Opioid-Related Disorders", "Substance-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Buprenorphine/naloxone"], "criteria": "Please contact site for information.", "gender": "All", "minimum_age": "19 Years", "maximum_age": "57 Years", "healthy_volunteers": "No", "keyword": "opiate dependence", "mesh_term": ["Disease", "Opioid-Related Disorders", "Substance-Related Disorders", "Naloxone", "Buprenorphine", "Buprenorphine, Naloxone Drug Combination"], "id": "NCT00000353"}